These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12393881

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
    Yue J, Mulder KM.
    J Biol Chem; 2000 Oct 06; 275(40):30765-73. PubMed ID: 10843986
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
    Ammanamanchi S, Kim SJ, Sun LZ, Brattain MG.
    J Biol Chem; 1998 Jun 26; 273(26):16527-34. PubMed ID: 9632722
    [Abstract] [Full Text] [Related]

  • 28. Cell-specificity of transforming growth factor-beta response is dictated by receptor bioavailability.
    Suszko MI, Woodruff TK.
    J Mol Endocrinol; 2006 Jun 26; 36(3):591-600. PubMed ID: 16720726
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S, Firth SM, Baxter RC.
    J Biol Chem; 2002 Mar 01; 277(9):7255-61. PubMed ID: 11751851
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Processing of the transforming growth factor beta type I and II receptors. Biosynthesis and ligand-induced regulation.
    Koli KM, Arteaga CL.
    J Biol Chem; 1997 Mar 07; 272(10):6423-7. PubMed ID: 9045666
    [Abstract] [Full Text] [Related]

  • 33. Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase.
    Yi JY, Shin I, Arteaga CL.
    J Biol Chem; 2005 Mar 18; 280(11):10870-6. PubMed ID: 15657037
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P, Lindh G, Bergh A, Damber JE.
    Urol Res; 1999 Jun 18; 27(3):185-93. PubMed ID: 10422820
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster.
    Bennett D, Alphey L.
    Nat Genet; 2002 Aug 18; 31(4):419-23. PubMed ID: 12134149
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.